Tech Company Financing Transactions
Therasis Funding Round
Private investors invested in a $12 million Series A funding round for Therasis. The financing round was announced on 12/8/2009.
Transaction Overview
Company Name
Announced On
12/8/2009
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Proceeds Purpose
The funds will allow the Company to launch and further develop its proprietary oncology drug discovery engine, the Therasis Filter�.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
462 First Avenue 908
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Website
Email Address
Overview
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Andrea Califano
Founder
Riccardo Dalla-Favera
Founder
Owen O'Connor
Browse more venture capital transactions:
Prev: 12/8/2009: Aiko Biotechnology venture capital transaction
Next: 12/8/2009: Coveo venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs